LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Painful Ophthalmoplegia: Aspergillosis, Tolosa-hunt and other Causes.

    Liesse, Antoine / Salerno, David

    Journal of the Belgian Society of Radiology

    2018  Volume 102, Issue 1, Page(s) 31

    Language English
    Publishing date 2018-02-27
    Publishing country England
    Document type Journal Article
    ISSN 2514-8281
    ISSN 2514-8281
    DOI 10.5334/jbsr.1496
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Painful Ophthalmoplegia

    Antoine Liesse / David Salerno

    Journal of the Belgian Society of Radiology, Vol 102, Iss

    Aspergillosis, Tolosa-hunt and other Causes

    2018  Volume 1

    Keywords Painful ophthalmoplegia ; Tolosa Hunt ; aspergillosis ; orbital apex ; cavernous sinus ; Medical physics. Medical radiology. Nuclear medicine ; R895-920
    Language English
    Publishing date 2018-02-01T00:00:00Z
    Publisher Ubiquity Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Diagnosis and Management of Pregnant Women With Placental Abruption and Neonatal Outcomes.

    Alouini, Souhail / Valery, Antoine / Lemaire, Bruno / Evrard, Marie-Liesse / Belin, Olivier

    Cureus

    2022  Volume 14, Issue 1, Page(s) e21120

    Abstract: Background Placenta abruptio (PA) remains a serious materno-fetal complication. According to progress realized in maternal-fetal medicine, we aimed to evaluate the diagnosis and management of PA and neonatal outcomes. Methods We conducted a retrospective ...

    Abstract Background Placenta abruptio (PA) remains a serious materno-fetal complication. According to progress realized in maternal-fetal medicine, we aimed to evaluate the diagnosis and management of PA and neonatal outcomes. Methods We conducted a retrospective study that involved all the patients that were diagnosed with PA in a tertiary maternity hospital between 2006 and 2013. Data were analyzed to determine mean and standard deviation and statistically analyzed using the Chi-square test. Results In total, 201 patients were diagnosed with PA out of 35184 deliveries (0.56%). The mean age of patients was 30 years and most of them were multiparous (56.2%). Thirty-six out of 201 patients (17.9%) smoked tobacco or consumed alcohol during the pregnancy. Three patients came from their homes. Twenty-eight patients had preeclampsia and 105 presented with high blood pressure. Furthermore, 117 patients presented metrorrhagia (58.2%) and 39% of patients exhibited abdominal pain. We reported fetal heart rate abnormalities in 57% of the cases. Ultrasound examination revealed PA in only 48 patients (23.9%). One hundred eighty out of 201 patients (84.6%) underwent an emergency caesarean section. One hundred sixty-seven fetuses were born prematurely. Thirteen out of 201 fetuses died, and 98 newborns needed neonatal resuscitation. In total, 31 fetuses had an umbilical artery (UA) with pH ≤ 7 (31/188). The mean time for delivery was 18.7 min. However, UA pH did not differ when the delivery time was shorter (p = 0.09). Seventy-six percent of cases came from their homes. The mean UA pH was significantly lower for PA cases who came from their homes compared to hospitalized women (p = 0.0015). Histological examination of the placenta confirmed the diagnosis in 71 out of 148 cases (47.9%). The mean duration of hospital stay of the newborns was 17 days. Conclusion PA remains a serious materno-fetal emergency with a bad fetal prognosis for many newborns. Many fetuses either died or exhibited severe acidosis. Clinical signs and radiological images of PA are absent in many cases. There was more fetal acidosis for mothers who came from their homes at the time of delivery. We recommend that the delivery should not be delayed and a cesarean section must be the preferred mode of delivery. Pregnant women with vascular and metabolic diseases should be carefully monitored and informed on the risk of PA.
    Language English
    Publishing date 2022-01-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.21120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Nonskeletal and skeletal effects of high doses versus low doses of vitamin D

    Courbebaisse, Marie / Bourmaud, Aurelie / Souberbielle, Jean-Claude / Sberro-Soussan, Rebecca / Moal, Valérie / Le Meur, Yannick / Kamar, Nassim / Albano, Laetitia / Thierry, Antoine / Dantal, Jacques / Danthu, Clément / Moreau, Karine / Morelon, Emmanuel / Heng, Anne-Elisabeth / Bertrand, Dominique / Arzouk, Nadia / Perrin, Peggy / Morin, Marie-Pascale / Rieu, Philippe /
    Presne, Claire / Grimbert, Philippe / Ducloux, Didier / Büchler, Matthias / Le Quintrec, Moglie / Ouali, Nacéra / Pernin, Vincent / Bouvier, Nicolas / Durrbach, Antoine / Alamartine, Eric / Randoux, Christine / Besson, Virginie / Hazzan, Marc / Pages, Justine / Colas, Sandra / Piketty, Marie-Liesse / Friedlander, Gérard / Prié, Dominique / Alberti, Corinne / Thervet, Eric

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

    2023  Volume 23, Issue 3, Page(s) 366–376

    Abstract: Vitamin D sufficiency is associated with a reduced risk of fractures, diabetes mellitus, cardiovascular events, and cancers, which are frequent complications after renal transplantation. The VITALE (VITamin D supplementation in renAL transplant ... ...

    Abstract Vitamin D sufficiency is associated with a reduced risk of fractures, diabetes mellitus, cardiovascular events, and cancers, which are frequent complications after renal transplantation. The VITALE (VITamin D supplementation in renAL transplant recipients) study is a multicenter double-blind randomized trial, including nondiabetic adult renal transplant recipients with serum 25-hydroxy vitamin D (25(OH) vitamin D) levels of <30 ng/mL, which is randomized 12 to 48 months after transplantation to receive high (100 000 IU) or low doses (12 000 IU) of cholecalciferol every 2 weeks for 2 months and then monthly for 22 months. The primary outcome was a composite endpoint, including diabetes mellitus, major cardiovascular events, cancer, and death. Of 536 inclusions (50.8 [13.7] years, 335 men), 269 and 267 inclusions were in the high-dose and low-dose groups, respectively. The serum 25(OH) vitamin D levels increased by 23 versus 6 ng/mL in the high-dose and low-dose groups, respectively (P < .0001). In the intent-to-treat analysis, 15% versus 16% of the patients in the high-dose and low-dose groups, respectively, experienced a first event of the composite endpoint (hazard ratio, 0.94 [0.60-1.48]; P = .78), whereas 1% and 4% of patients in the high-dose and low-dose groups, respectively, experienced an incident symptomatic fracture (odds ratio, 0.24 [0.07-0.86], P = .03). The incidence of adverse events was similar between the groups. After renal transplantation, high doses of cholecalciferol are safe but do not reduce extraskeletal complications (trial registration: ClinicalTrials.gov; identifier: NCT01431430).
    MeSH term(s) Male ; Adult ; Humans ; Cholecalciferol/adverse effects ; Kidney Transplantation/adverse effects ; Vitamin D/therapeutic use ; Vitamins/adverse effects ; Double-Blind Method ; Dietary Supplements ; Cardiovascular Diseases/etiology ; Vitamin D Deficiency/complications ; Vitamin D Deficiency/drug therapy
    Chemical Substances Cholecalciferol (1C6V77QF41) ; Vitamin D (1406-16-2) ; Vitamins
    Language English
    Publishing date 2023-01-09
    Publishing country United States
    Document type Randomized Controlled Trial ; Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2060594-8
    ISSN 1600-6143 ; 1600-6135
    ISSN (online) 1600-6143
    ISSN 1600-6135
    DOI 10.1016/j.ajt.2022.12.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Rendu des résultats de dosage de l’hormone de croissance en μg/L : la fin de la résistance des irréductibles Gaulois.

    Chanson, Philippe / Reynaud, Rachel / Coutant, Régis / Linglart, Agnès / Nicolino, Marc / Rodien, Patrice / Borson-Chazot, Françoise / Tabarin, Antoine / Le Bouc, Yves / Piketty, Marie-Liesse / Gauchez, Anne-Sophie / Chevenne, Didier / Porquet, Dominique / Souberbielle, Jean-Claude

    Annales de biologie clinique

    2018  Volume 76, Issue 2, Page(s) 133–134

    Title translation Serum GH concentration must now be expressed in mass units in France like in the rest of the world.
    MeSH term(s) Diagnostic Techniques, Endocrine/standards ; France ; Geography ; Human Growth Hormone/analysis ; Human Growth Hormone/blood ; Humans ; Internationality ; Osmolar Concentration ; Reference Standards
    Chemical Substances Human Growth Hormone (12629-01-5)
    Language French
    Publishing date 2018-02-14
    Publishing country France
    Document type Editorial
    ZDB-ID 418098-7
    ISSN 1950-6112 ; 0003-3898
    ISSN (online) 1950-6112
    ISSN 0003-3898
    DOI 10.1684/abc.2018.1322
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Serum GH concentrations must now be expressed in mass units in France…as in the rest of the world.

    Chanson, Philippe / Reynaud, Rachel / Coutant, Régis / Linglart, Agnès / Nicolino, Marc / Rodien, Patrice / Borson-Chazot, Françoise / Tabarin, Antoine / Le Bouc, Yves / Piketty, Marie-Liesse / Gauchez, Anne-Sophie / Chevenne, Didier / Porquet, Dominique / Souberbielle, Jean-Claude

    Annales d'endocrinologie

    2017  Volume 78, Issue 6, Page(s) 488–489

    MeSH term(s) Data Interpretation, Statistical ; France ; Growth Hormone/blood ; Human Growth Hormone/blood ; Humans
    Chemical Substances Human Growth Hormone (12629-01-5) ; Growth Hormone (9002-72-6)
    Language English
    Publishing date 2017-12
    Publishing country France
    Document type Editorial
    ZDB-ID 299-9
    ISSN 2213-3941 ; 0003-4266
    ISSN (online) 2213-3941
    ISSN 0003-4266
    DOI 10.1016/j.ando.2017.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top